Primary Site >> Colorectal Cancer
Gene >> SMAD1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of Smad proteins in human colorectal cancer. PMID: 10389752 Ref: Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. PMID: 10446110 |
Ref: Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. PMID: 14699493 |
Ref: Bone morphogenetic protein signaling and growth suppression in colon cancer. PMID: 16769811 |
Ref: BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. PMID: 17317101 |
Ref: The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. PMID: 18008360 Ref: Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. PMID: 18381431 Ref: Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells. PMID: 18414391 |
Ref: Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. PMID: 20065295 |
Ref: Genetic variation in the TGF-beta signaling pathway and colon and rectal cancer risk. PMID: 21068203 Ref: Genetic variation in the transforming growth factor-beta signaling pathway and survival after diagnosis with colon and rectal cancer. PMID: 21365634 |
Ref: Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-beta/endoglin signaling. PMID: 23209720 |
Ref: Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFbeta1-targeting peptides P17 and P144. PMID: 23153552 Ref: Evaluation of the prognostic value of pSMAD immunohistochemistry in colorectal cancer. PMID: 23426176 |
Ref: Soy promotes juvenile granulosa cell tumor development in mice and in the human granulosa cell tumor-derived COV434 cell line. PMID: 25165122 |
Ref: MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling. PMID: 24882581 Ref: P53 deficiency-induced Smad1 upregulation suppresses tumorigenesis and causes chemoresistance in colorectal cancers. PMID: 25757624 Ref: Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth. PMID: 26029998 Ref: BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation. PMID: 26124007 |
Ref: Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK. PMID: 26986967 Ref: Neogenin Promotes BMP2 Activation of YAP and Smad1 and Enhances Astrocytic Differentiation in Developing Mouse Neocortex. PMID: 27225772 |
Ref: Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis. PMID: 28009989 Ref: Genome-wide network-based pathway analysis of CSF t-tau/Abeta1-42 ratio in the ADNI cohort. PMID: 28558704 Ref: BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells. PMID: 28731124 Ref: Smad1 promotes colorectal cancer cell migration through Ajuba transactivation. PMID: 29299158 |
Ref: Multispectral imaging reveals hyper active TGF-beta signaling in colorectal cancer. PMID: 29219668 Ref: Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling. PMID: 30132514 Ref: Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling. PMID: 30132516 |